Question
Carriers in Hepatitis B virus infection
Answer
Carriers in Hepatitis B virus (HBV) infection are individuals who remain persistently HBsAg-positive for more than 6 months without necessarily showing overt clinical symptoms of active hepatitis — i.e., they harbour chronic HBV infection and can transmit the virus to others, despite often being asymptomatic themselves.
Types:
- Healthy (asymptomatic) carriers — HBsAg-positive, but with normal liver function tests and minimal/no ongoing liver inflammation; generally have low viral replication (HBeAg-negative, low/undetectable HBV DNA) and a good long-term prognosis, though they remain infectious and require periodic monitoring for possible reactivation.
- Chronic active carriers — HBsAg-positive with ongoing active viral replication (often HBeAg-positive, high HBV DNA) and evidence of ongoing liver inflammation/damage (raised ALT/AST), carrying a significant long-term risk of progression to cirrhosis and hepatocellular carcinoma if untreated.
Clinical/public health significance: carriers are a major reservoir for continued HBV transmission (via blood, sexual contact, or perinatal transmission from a carrier mother to her infant) — a chronic carrier mother who is HBeAg-positive carries a particularly high risk of transmitting HBV to her newborn during delivery, making maternal HBV screening and neonatal post-exposure prophylaxis (HBIG plus vaccine at birth) an essential public health intervention.
Monitoring: carriers require periodic follow-up (liver function tests, HBV DNA, and periodic imaging/alpha-fetoprotein screening for hepatocellular carcinoma surveillance in high-risk carriers), since the carrier state can persist for decades and silently progress to serious liver disease.